Generated by Rank Math SEO, this is an llms.txt file designed to help LLMs better understand and index this website.

# MyBiotech GmbH: MyBiotech is a Germany-based Contract Development and Manufacturing Organization (CDMO) focused on nanoparticle and advanced drug delivery products. We support pharmaceutical, biotech, and innovator teams from early development through GMP manufacturing—combining deep formulation expertise with robust quality systems and modern cleanroom infrastructure.

## Sitemaps
[XML Sitemap](https://www.mybiotech.de/sitemap_index.xml): Includes all crawlable and indexable pages.

## Pages
- [Homepage](https://www.mybiotech.de/): A nanomedicine CDMO supports the development and manufacturing of nanoparticle-based drug products—covering formulation and process development, scale-up, GMP manufacturing, aseptic fill & finish, QC, stability studies, and CMC documentation.
- [Career](https://www.mybiotech.de/career-at-mybiotech/): Help translate breakthrough formulations into real-world therapies with hands-on development, scale-up, and manufacturing
- [About Us](https://www.mybiotech.de/about-us-nanomedicine-cdmo/): We are structured to be responsive and hands-on. Clients value our scientific leadership, transparent communication, and flexibility—especially for challenging formulations, accelerated timelines, and programs that require close technical partnership.
- [Site Notice](https://www.mybiotech.de/site-notice/): MyBiotech GmbH
- [Privacy Policy](https://www.mybiotech.de/privacy-policy/): The following information will provide you with an easy to navigate overview of what will happen with your personal data when you visit this website. The term “personal data” comprises all data that can be used to personally identify you. For detailed information about the subject matter of data protection, please consult our Data Protection Declaration, which we have included beneath this copy.
- [Disclaimer](https://www.mybiotech.de/disclaimer/): The content on this website (including all downloadable materials such as brochures, whitepapers, technical sheets, presentations, and other files) is provided for general informational and marketing purposes only and is intended exclusively for business customers (B2B). It is not directed at consumers.
- [Quality Control](https://www.mybiotech.de/nanomedicine-qc/): All analytical activities follow fit-for-phase approaches aligned with ICH expectations and GMP principles. Our QC laboratory provides broad analytical expertise including advanced chromatography, dissolution testing, Karl Fischer titration and validated GMP analytical methods—supporting method lifecycle management from development through clinical supply.
- [GMP Manufacturing](https://www.mybiotech.de/gmp-nanomedicine-manufacturing/): End-to-end GMP services for nanomedicines—formulation, production for clinics, aseptic Fill & Finish, lyophilization, QC, stability, and batch release—backed by a phase-appropriate CMC and control strategy. We ensure robust documentation, comparability across scale, and stability-indicating analytics to support IND/IMPD timelines. For batch release and logistics, we coordinate QP-ready documentation, release testing completion, and shipment planning (to ensure on-time, compliant delivery.
- [Services](https://www.mybiotech.de/nanomedicine-cdmo-services/): We support nanoparticle drug products and nanotechnology enabled drug products across platforms such as lipid nanoparticles (LNPs), polymer nanoparticles, liposomes, nanoemulsions, micelles, and other complex particulate systems—designed for oral, injectable, and topical applications. As your program advances, we translate development work into reproducible, compliant production—covering all CMC services, technical transfer, scale-up, process definition, and GMP-aligned documentation. 
- [Scale Up](https://www.mybiotech.de/nanomedicine-scale-up/): MyBiotech scales complex nanoparticle processes from laboratory scale to preclinical and clinical manufacturing volumes with a proven, structured approach. We define critical process parameters, protect critical quality attributes (CQAs), and translate development work into robust, reproducible production. Nanomedicine scale-up from pilot and preclinical batches to GMP-ready tech transfer, we help reduce risk and shorten timelines on the path to clinic.
- [Contact us](https://www.mybiotech.de/contact-us/): We’re here to support your questions and collaborations
- [Aseptic Fill and Finish](https://www.mybiotech.de/nanomedicine-sterile-manufacturing/): Flexible aseptic fill and finish for clinical trial materials, personalized medicines, and advanced therapeutic products
- [Research and Development](https://www.mybiotech.de/nanomedicine-rd-services/): MyBiotech has deep expertise in developing both oral and parenteral dosage forms from early feasibility studies to formulation optimization and clinical manufacturing.Our teams work across small molecules, biologics, and complex APIs to create stable, scalable, and high-performance drug products tailored to your delivery route.

## ElementsKit items
- [dynamic-content-widget-2ebf46c1-99](https://www.mybiotech.de/elementskit-content/dynamic-content-widget-2ebf46c1-99/): Homepage
Services Research and Development	Scale Up	GMP Manufacturing	Aseptic Fill and Finish	Quality Control About Us
News&Events
Career
X

## Templates
- [Footer](https://www.mybiotech.de/?elementskit_template=footer): Stay informed, connect with our experts, and discover how MyBiotech advances nanomedicine through trusted technologies and GMP manufacturing solutions.
- [header](https://www.mybiotech.de/?elementskit_template=header): Homepage Services Research and Development Scale Up GMP Manufacturing Aseptic Fill and Finish Quality Control About Us News&Events Career Contact us